ReleaseWire Connect

“Zontivity (Acute Coronary Syndrome) Forecast and Market Analysis to 2023?. The current ACS market primarily comprised of antithrombotics, antihypertensives, and statins is flush with well-established standard-of-care therapies, many of which are generic. Therefore, the pipeline therapies that show the most promise exploit novel mechanisms of action and target orphan biochemical pathways. The ACS market will be driven by an aging population with a preponderance of lifestyle-based diseases, such as obesity, and the growing prevalence of metabolic disorders such as diabetes. The expansion of biologics into the ACS mainstream during the ten year forecast period is expected to significantly and fundamentally alter the ACS market, both medically and financially.

“North America Non-Vascular Stents Market Outlook to 2020, provides key market data on the North America Non-Vascular Stents market.

“Canada Non-Vascular Stents Market Outlook to 2020?, provides key market data on the Canada Non-Vascular Stents market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments – Biliary Stents (Plastic Biliary Stents and Metal Biliary Stents (Metal Non-Covered Biliary Stents, Metal Partially Covered Biliary Stents and Metal Fully Covered Biliary Stents)), Gastrointestinal Stents (Fully Covered, Partially Covered and Non-Covered Gastrointestinal Stents), Airway Stents (Silicone Airway Stents and Metallic Airway Stents (Fully Covered and Uncovered Metallic Airway Stents) and Urinary Tract Stents ((Ureteral Stents (Metal, Polymer and Bioabsorbable Ureteral Stents), Prostate Stents (Metal, Polymer and Bioabsorbable Prostate Stents) and Urethral Stents (Metal, Polymer and Bioabsorbable Urethral Stents)).

“Heart Valve Disease Global Clinical Trials Review, H2, 2014? provides data on the Heart Valve Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Heart Valve Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Heart Valve Disease.

“Spain Bronchoscopes Market Outlook to 2020?, provides key market data on the Spain Bronchoscopes market. The report provides value, in millions of US dollars, volume (in units) and average prices (in US dollars) within market segments – Video Bronchoscopes (Flexible Video Bronchoscopes and Portable Video Bronchoscopes) and Non-Video Bronchoscopes (Rigid Non-Video Bronchoscopes and Flexible Non-Video (Fibre) Bronchoscopes).